ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,431.60
-0.04%
Dow Jones
38,589.16
-0.15%
US Dollar vs MXN
18.4648
0.00%
Brent Oil
82.275
0.00%
Bitcoin
66,451.47
0.39%
Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Regístrate
  1. Inicio
  2. Invertir
  3. ETFs
  4. Canadá
  5. TSX
  6. iShares S&P TSX Canadian Preferred Share Index ETF (CPD)

  7. iShares S&P TSX Canadian Preferred Share Index ETF (CPD) Noticias

CPD

iShares S&P TSX Canadian... (CPD)

iShares S&P TSX Canadian Preferred Share Index ETF
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:TSX:CPD
FechaHoraFuenteTítuloSímboloCompañía
15/11/201204:00Marketwired CanadaCanadian Zinc Reports Financial and Operating Results for Third Quarter 2012TSX:CPDiShares S&P TSX Canadian Preferred Share Index ETF
16/05/201205:00Marketwired CanadaCanadian Zinc Reports Financial Results for First Quarter 2012TSX:CPDiShares S&P TSX Canadian Preferred Share Index ETF
28/01/201016:43PR Newswire (US)Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the Third Quarter and First Nine Months of Fiscal Year 2010AMEX:CPD
18/11/200909:20PR Newswire (US)Caraco Pharmaceutical Laboratories, Ltd. Markets Nicardipine Hydrochloride InjectionAMEX:CPD
06/11/200909:36PR Newswire (US)Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Acular(R) Ophthalmic SolutionAMEX:CPD
06/11/200908:53PR Newswire (US)Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Acular(R) Opthalmic SolutionAMEX:CPD
27/10/200910:59PR Newswire (US)/C O R R E C T I O N -- Caraco Pharmaceutical Laboratories, Ltd./AMEX:CPD
27/10/200908:13PR Newswire (US)Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the Second Quarter and First Six Months of Fiscal Year 2010AMEX:CPD
02/10/200908:05PR Newswire (US)Caraco Pharmaceutical Laboratories, Ltd. Closes Asset Purchase Agreement with Forest Laboratories, Inc. to Settle Lexapro(R) (esAMEX:CPD
29/09/200915:01PR Newswire (US)Caraco Pharmaceutical Laboratories, Ltd. Enters Into Consent Decree with FDA Providing Path to Resume Manufacturing OperationsAMEX:CPD
23/09/200916:00PR Newswire (US)Caraco Pharmaceutical Laboratories, Ltd. Announces Resignation of Georges Ugeux from Board of DirectorsAMEX:CPD
15/09/200908:08PR Newswire (US)Caraco Pharmaceutical Laboratories, Ltd. Announces Appointment of F. Folsom Bell to Board of DirectorsAMEX:CPD
27/08/200909:34PR Newswire (US)Caraco Pharmaceutical Laboratories, Ltd. Announces Reversal of Summary Judgment in Ultracet(R) ANDA Patent LitigationAMEX:CPD
11/08/200917:37PR Newswire (US)Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Imitrex(R) TabletsAMEX:CPD
02/08/200923:22PR Newswire (US)Caraco Pharmaceutical Laboratories, Ltd. Announces Settlement of Ethyol(R) ANDA Patent LitigationAMEX:CPD
28/07/200918:30PR Newswire (US)Caraco Pharmaceutical Laboratories, Ltd. Announces Change to Executive Team as Jitendra N. Doshi Assumes Position of CEOAMEX:CPD
28/07/200915:42PR Newswire (US)Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2010AMEX:CPD
23/07/200918:01PR Newswire (US)Caraco Pharmaceutical Laboratories, Ltd. Announces Filing of Purported Class Action LawsuitsAMEX:CPD
10/07/200908:15PR Newswire (US)Caraco Pharmaceutical Laboratories, Ltd. Enters Into Asset Purchase Agreement with Forest Laboratories, Inc. to Settle Lexapro(RAMEX:CPD
07/07/200910:44PR Newswire (US)Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Casodex(R) TabletsAMEX:CPD
06/07/200908:04PR Newswire (US)Caraco Pharmaceutical Laboratories, Ltd. Announces an Indefinite Reduction in its WorkforceAMEX:CPD
26/06/200908:15PR Newswire (US)Caraco Pharmaceutical Laboratories, Ltd. Updates on Financial PositionAMEX:CPD
25/06/200921:09PR Newswire (US)Caraco Pharmaceutical Laboratories, Ltd. Announces FDA ActionAMEX:CPD
28/05/200918:51PR Newswire (US)Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the Fiscal Year 2009, Updates on FDA InspectionAMEX:CPD
14/05/200909:24PR Newswire (US)Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Roxicodone(R) TabletsAMEX:CPD
02/04/200909:03PR Newswire (US)Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Topamax(R) TabletsAMEX:CPD
31/03/200913:50PR Newswire (US)Caraco Pharmaceutical Laboratories, Ltd. Announces a Nationwide Voluntary Recall of All Lots of Digoxin Tablets Due to Size VariAMEX:CPD
29/01/200909:41PR Newswire (US)Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the Third Quarter and First Nine Months of Fiscal 2009AMEX:CPD
22/01/200908:24PR Newswire (US)Caraco Pharmaceutical Laboratories, Ltd. to Announce Third Quarter of Fiscal Year 2009 Results on January 29, 2009AMEX:CPD
24/11/200819:00PR Newswire (US)Caraco Pharmaceutical Laboratories, Ltd. Responds to FDA Warning LetterAMEX:CPD
 Showing the most relevant articles for your search:TSX:CPD

Su Consulta Reciente

COIN
BTCUSD
Bitcoin
FX
EURMXN
Euro vs MXN
USOTC
ADDYY
Adidas (QX)
AMEX
XLF
Financial Select Sector
NYSE
KO
Coca Cola
NYSE
MRK
Merck
NYSE
BAC
Bank of America
CCOM
OILBRENT
Brent Oil
NYSE
MCD
McDonalds
USOTC
DTEGY
Deutsche Telekom (QX)
NYSE
JPM
JP Morgan Chase
NASDAQ
MSFT
Microsoft
USOTC
BNPQY
BNP Paribas (QX)
USOTC
BASFY
BASF (QX)
NASDAQ
QQQ
Invesco QQQ Trust Series 1
CCOM
US500
US 500
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados